Side Effects of Drugs Annual, Volume 29

1st Edition

A Worldwide Yearly Survey of New Data and Trends in Adverse Drug Reactions

Editors: Jeffrey K. Aronson
Hardcover ISBN: 9780444519863
eBook ISBN: 9780080522814
Imprint: Elsevier Science
Published Date: 9th May 2007
Page Count: 714
390.00 + applicable tax
240.00 + applicable tax
300.00 + applicable tax
353.00 + applicable tax
Unavailable
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access


Table of Contents

Contributors

Special reviews

Cumulative index of special reviews, Annuals 14–28

Table of Essays, Annuals 1–28

DoTS classification of adverse drug reactions

How to use this book

Data mining in drug safety

1 Central nervous system stimulants and drugs that suppress appetite

Methylxanthines (SEDA-26, 1; SEDA-27, 1; SEDA-28, 1)

Amphetamines (SED-15, 180; SEDA-26, 30; SEDA-27, 29; SEDA-28, 4, 28)

Drugs that suppress appetite (SEDA-26, 6; SEDA-27, 4; SEDA-28, 6)

Drugs used in Alzheimer's disease (SEDA-26, 7; SEDA-27, 7; SEDA-28, 9)

2 Antidepressant drugs

Mania as an adverse effect of antidepressants

Monoamine oxidase inhibitors (SED-15, 2371; SEDA-24, 12)

Tricyclic antidepressants (SED-15, 3489; SEDA-26, 11; SEDA-27, 11; SEDA-28, 15)

Selective serotonin re-uptake inhibitors (SSRIs) (SED-15, 3109; SEDA-26, 11; SEDA-27, 12; SEDA-28, 15)

Serotonin and noradrenaline re-uptake inhibitors (SNRIs)

Other antidepressants

3 Lithium

4 Drugs of abuse

Cannabinoids (SED-15, 614; SEDA-26, 36; SEDA-27, 32; SEDA-28, 36)

Cocaine (SED-15, 848; SEDA-26, 27; SEDA-27, 33; SEDA-28, 38; see also Chapter 11)

Opioid analgesics (SED-15, 2619; SEDA-27, 38; SEDA-28, 44)

5 Hypnosedatives and anxiolytics

Azaspirones (SEDA-26, 49; SEDA-27, 43; SEDA-28, 52)

Benzodiazepines (SED-15, 429; SEDA-26, 46; SEDA-27, 43; SEDA-28, 52)

Other hypnotics and sedatives

6 Antipsychotic drugs

General (SED-15, 2438)

Individual drugs

7 Antiepileptic drugs

8 Opioid analgesics and narcotic antagonists

Opioid receptor agonists

Partial opioid receptor agonists

Opioid receptor antagonists

Miscellaneous compounds

9 Anti-inflammatory and antipyretic analgesics and drugs used in gout

Coxibs and cardiovascular disease

Indi


Description

The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has contributed to the Annuals by selecting critically from each year's writing all that is truly new and informative, by critically interpreting it, and by pointing to whatever is misleading.

Key Features

  • Provides a critical yearly survey of new data and trends
  • Includes an essay that describes the modern approach to classifying adverse drug reactions
  • Special reviews in this Annual include, among other topics: Antipsychotic drugs and now-onset diabetes mellitus, Treating asthma during pregnancy, and MMR vaccine and autism

Readership

Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, Clinical pharmacologists, and medical libraries


Details

No. of pages:
714
Language:
English
Copyright:
© Elsevier Science 2007
Published:
Imprint:
Elsevier Science
eBook ISBN:
9780080522814
Hardcover ISBN:
9780444519863

About the Editors

Jeffrey K. Aronson Editor

Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK’s National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.

Affiliations and Expertise

Department of Primary Health Care, University of Oxford, Oxford, UK